Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Kardigan, Inc.
KARD · SEC Filings
website
241
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medic...
Price
15.18
Market Cap
1.36 B
Float
51.76 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about KARD
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Kardigan, Inc.
KARD · SEC Filings
51.76 M
Float
15.18
Price
1.36 B
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2026
News
TYPE
HEADLINE
FILED AT
8-K
Kardigan Completes Enrollment in Phase 2b KATALYST-AV Trial for Ataciguat in Aortic Stenosis and Updates Development Timeline
Nov 6, 2026
8-K
Kardigan Appoints Kristin Reinke to Board of Directors and Audit Committee Chair
Sep 30, 2026
8-K
Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates
Aug 11, 2026
8-K
Kardigan, Inc. Files Amended and Restated Certificate of Incorporation and Bylaws in Connection with IPO
Jun 23, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B4
IPO | Offering amount: $400,000,000 | Shares: 25,000,000 | Price: $16.000 | Bank: J.P. Morgan, Jefferies, Leerink Partners, TD Cowen
Jun 18, 2026
Registrations
TYPE
HEADLINE
FILED AT
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
4
Reinke Kristin Marie K (Reporting)
Oct 1, 2026
3
Reinke Kristin Marie K (Reporting)
Oct 1, 2026
SCHEDULE 13D/A
PERCEPTIVE ADVISORS LLC (Filed by)
Oct 1, 2026
SCHEDULE 13G
GIANAKAKOS ANASTASIOS (Filed by)
Aug 13, 2026
SCHEDULE 13G
Edelberg Jay (Filed by)
Aug 13, 2026
SCHEDULE 13G/A
FMR LLC (Filed by)
Aug 7, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Jun 18, 2026
